Literature DB >> 19904768

MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands.

Heng Zheng1, Caitlin A Heiderscheidt, Myung Joo, Xeipei Gao, Nebojsa Knezevic, Dolly Mehta, Ruxana T Sadikot.   

Abstract

Triggering receptor expressed on myeloid cells (TREM)-1 plays an important role in myeloid cell-activated inflammatory responses. Although TLR ligands such as LPS and lipoteichoic acid have been shown to upregulate TREM-1 expression in macrophage and neutrophils, the role of specific TLR in inducing the expression of TREM-1 remains unclear. In this study, we investigated whether the presence of TLR is necessary for the expression of TREM-1. We show that BM-derived macrophages from TLR4 and TLR2 KO mice failed to induce expression of TREM-1 message and protein in response to their specific ligands. Interestingly, the expression of TREM-1 in response to LPS is not altered in myeloid differentiation factor 88 (MyD88) KO macrophages, suggesting that downstream of TLR a MyD88-independent pathway induces the expression of TREM-1. Inhibiting toll/IL-1R domain-containing adaptor-inducing IFN-beta (TRIF) expression by siRNA decreased TREM-1 expression in response to LPS, suggesting that the expression of TREM-1 in response to LPS was mediated by the TRIF signaling pathway. On the other hand, the expression of TREM-1 in response to lipoteichoic acid is dependent on MyD88 expression. These data indicate that the expression of TREM-1 in response to TLR ligands occurs secondary to downstream signaling events and that the presence of TLR is necessary for the expression of TREM-1 in response to their specific ligands. However, the downstream signaling required for the expression of TREM-1 is dependent on the stimulus and the surface receptor through which the signaling is initiated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19904768     DOI: 10.1002/eji.200839156

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

2.  Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations.

Authors:  Saravanan Subramanian; Pradeep K Pallati; Poonam Sharma; Devendra K Agrawal; Kalyana C Nandipati
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

Authors:  Lisa Volk-Draper; Kelly Hall; Caitlin Griggs; Sandeep Rajput; Pascaline Kohio; David DeNardo; Sophia Ran
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

4.  Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

Authors:  Marc Derive; Frédéric Massin; Sébastien Gibot
Journal:  Self Nonself       Date:  2010-07-02

5.  Ameliorative effects of glycine in an experimental nonalcoholic steatohepatitis and its correlation between TREM-1 and TREM-2.

Authors:  Zhang-Feng Dou; Ya-Rong Guo; Jin-Chun Liu; Ning Li; Bao Chai; Xiu-Qing Li; Rong Fu; Xiao-Juan Wang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 6.  Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis.

Authors:  Steven J Palazzo; Terri Simpson; Lynn M Schnapp
Journal:  Dimens Crit Care Nurs       Date:  2012 Jan-Feb

7.  Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival.

Authors:  Zhihong Yuan; Mansoor Ali Syed; Dipti Panchal; Myungsoo Joo; Marco Colonna; Mark Brantly; Ruxana T Sadikot
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

8.  TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.

Authors:  Zhihong Yuan; Mansoor Syed; Dipti Panchal; Myungsoo Joo; Chetna Bedi; Sokbee Lim; Hayat Onyuksel; Israel Rubinstein; Marco Colonna; Ruxana T Sadikot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

9.  TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses.

Authors:  Minhao Wu; Anping Peng; Mingxia Sun; Qiuchan Deng; Linda D Hazlett; Jin Yuan; Xialin Liu; Qianying Gao; Lianqiang Feng; Junfang He; Ping Zhang; Xi Huang
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

10.  Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.

Authors:  Liang Dong; Yong Zhou; Zhao-Qiong Zhu; Tian Liu; Jia-Xi Duan; Jun Zhang; Ping Li; Bruce D Hammcok; Cha-Xiang Guan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.